Brief: Harrow Announces Product-Specific J-Code (J2403) For Iheezo
02/02/2023 12:57
Feb 2 (Reuters) - Harrow Health Inc HROW.O :
* HARROW ANNOUNCES PERMANENT, PRODUCT-SPECIFIC J-CODE
(J2403) FOR
IHEEZO™ (CHLOROPROCAINE HYDROCHLORIDE OPHTHALMIC GEL) 3% FOR
OCULAR SURFACE ANESTHESIA EFFECTIVE APRIL 1, 2023
Source text for Eikon: ID:nBw7XMLsva
Further company coverage: HROW.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Harrow
See all newsHarrow, Inc. reports results for the quarter ended June 30 - Earnings Summary
Harrow Q2 revenue slightly beats estimates
Viatris raises annual profit forecast on branded drug strength
Brief: Harrow Re-Launches Verkazia® (Cyclosporine Ophthalmic Emulsion) 0.1% For Vernal Keratoconjunctivitis, Addressing Significant Unmet Need In Pediatric Eyecare
Harrow Q1 revenue misses analyst estimates